EUVIMEDEUVIMED entdecken
Crossref

Impact of Pharmacist-Led Education on Proper Prophylactic Enoxaparin Dosing in Obese Patients

Brianna R Kempema Nelson iD, Carly L Wehner, Irina V Haller, Colleen M Renier

Journal of Pharmacy Practice · 2024

DOI: 10.1177/08971900231193548 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy Practice, 2024. Verfasst von Brianna R Kempema Nelson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Inpatient Pharmacy, Essentia Health, Fargo, ND, USA. Hauptthemen laut MEDLINE: Enoxaparin, Pharmacists, Venous Thromboembolism, Anticoagulants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Purpose: Venous thromboembolism (VTE) is a common cardiovascular complication in middle-aged adults. There is a likelihood a patient may experience VTE when admitted to a hospital. Prophylactic medications such as low-dose unfractionated heparin and enoxaparin are started to prevent VTE. A pharmacist-led health system-wide Grand Rounds promoted prophylactic enoxaparin 40 mg twice daily instead of once daily in patients with a body mass index (BMI) 40 kg/m 2 or greater. Methodology: This case-control study was conducted at a Essentia Health – Fargo, in the Upper Midwest. Data of acute care patients were extracted from electronic health records 2 years before and after the pharmacist-led education. Patients in the study were 18 years old or older, hospitalized with a need for prophylactic anticoagulation receiving enoxaparin, and had a BMI 40 kg/m 2 or greater. Patients with a diagnosis of COVID-19 and recent bleeding were excluded. Groups were compared to determine the effect of pharmacist-led education. The outcome was the number of patients who received enoxaparin 40 mg twice daily compared to once daily.

Results

In the control group, 9 out of 15 hospitalizations received enoxaparin 40 mg subcutaneous twice daily and in the case group 34 out of 70 hospitalizations received the twice daily dosing. The odds ratio of receiving enoxaparin 40 mg twice daily after the pharmacist-led education compared to before the education was OR = .99, 95% CI = .96, 1.02.

Conclusions

There was no difference in enoxaparin 40 mg once daily and twice daily dosing after the pharmacist-led education.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EnoxaparinPharmacistsVenous ThromboembolismAnticoagulantsObesityHumansMaleFemaleMiddle AgedCase-Control StudiesAgedAdultBody Mass IndexProfessional RolePatient Education as TopicPharmacy Service, Hospital

Stichwörter der Autor:innen

body mass indexenoxaparinobesepharmacist-led educationvenous thromboembolism prophylaxis

Substanzen

EnoxaparinAnticoagulants

Autor:innen und Institutionen

  • Department of Inpatient Pharmacy, Essentia Health, Fargo, ND, USA.
  • Department of Research, Essentia Institute of Rural Health, Duluth, MN, USA.

ORCID-Profile: Brianna R Kempema Nelson

Zitieren

APA

Kempema Nelson, B. R., Wehner, C. L., Haller, I. V., & Renier, C. M. (2024). Impact of Pharmacist-Led Education on Proper Prophylactic Enoxaparin Dosing in Obese Patients. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900231193548

Vancouver

Kempema Nelson BR, Wehner CL, Haller IV, Renier CM. Impact of Pharmacist-Led Education on Proper Prophylactic Enoxaparin Dosing in Obese Patients. Journal of Pharmacy Practice. 2024. doi:10.1177/08971900231193548

BibTeX
@article{KempemaNelson2024,
  author = {Kempema Nelson, Brianna R and Wehner, Carly L and Haller, Irina V and Renier, Colleen M},
  title = {Impact of Pharmacist-Led Education on Proper Prophylactic Enoxaparin Dosing in Obese Patients},
  journal = {Journal of Pharmacy Practice},
  year = {2024},
  doi = {10.1177/08971900231193548}
}
Kostenlos starten →